The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Toward theragnostics
Abstract
Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results. Bioinformatics, genomics, proteomics, and functional genomics are molecular biology tools essential for the progress of molecular theragnostics. These tools generate the genetic and protein information required for the development of diagnostic assays. Theragnostics includes a wide range of subjects, including personalized medicine, pharmacogenomics, and molecular imaging to develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimize drug selection. Furthermore, theragnostics aims to monitor the response to the treatment, to increase drug efficacy and safety. In addition, theragnostics could eliminate the unnecessary treatment of patients for whom therapy is not appropriate, resulting in significant drug cost savings for the healthcare system. However, the introduction of theragnostic tests into routine health care requires both a demonstration of cost-effectiveness and the availability of appropriate accessible testing systems. This review reports validation studies in oncology and infectious diseases that have demonstrated the benefits of such approach in well-defined subpopulations of patients, moving the field from the drug development process toward clinical practice and routine application. Theragnostics may change the usual business model of pharmaceutical companies from the classic blockbuster model toward targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Research works printed but not linked: 41
- Wilson, 2007, Clin Pharmacol Ther, 81, 153, 10.1038/sj.clpt.6100088 · DOI
- Ozdemir, 2006, Nat Biotechnol, 24, 942, 10.1038/nbt0806-942 · DOI
- Dawood, 2008, Semin Oncol, 35, 64, 10.1053/j.seminoncol.2007.11.012 · DOI
- Revillion, 2008, Ann Oncol, 19, 73, 10.1093/annonc/mdm431 · DOI
- Olver, 2008, Future Oncol, 4, 125, 10.2217/14796694.4.1.125 · doi:10.2217/14796694.4.1.125
- Jabbour, 2008, Expert Rev Anticancer Ther, 8, 99, 10.1586/14737140.8.1.99 · DOI
- Wheatley-Price, 2008, Curr Opin Oncol, 20, 162, 10.1097/CCO.0b013e3282f335a3 · DOI
- Eberhard, 2008, J Clin Oncol, 26, 983, 10.1200/JCO.2007.12.9858 · DOI · Paper page
- Lander, 2001, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
- Craddock, 2007, Clin Med, 7, 632, 10.7861/clinmedicine.7-6-632 · doi:10.7861/clinmedicine.7-6-632
- de Kogel, 2007, Oncologist, 12, 1390, 10.1634/theoncologist.12-12-1390 · doi:10.1634/theoncologist.12-12-1390
- Fatouros, 2008, Ann Surg Oncol, 15, 21, 10.1245/s10434-007-9612-4 · DOI
- Roukos, 2007, Nat Clin Pract Oncol, 4, 578, 10.1038/ncponc0930 · DOI
- Calin, 2006, Nat Rev Cancer, 6, 857, 10.1038/nrc1997 · DOI · Paper page
- Sears, 2007, Adv Cancer Res, 96, 51, 10.1016/S0065-230X(06)96003-5 · DOI
- Reis-Filho, 2006, J Clin Pathol, 59, 225, 10.1136/jcp.2005.028324 · DOI
- Blenkiron, 2007, Hum Mol Genet, 16, R106, 10.1093/hmg/ddm056 · DOI · Paper page
- Schetter, 2008, JAMA, 299, 425
- Cooper, 2004, BMJ, 329, 533, 10.1136/bmj.329.7465.533 · DOI · Paper page
- Huletsky, 2005, Clin Infect Dis, 40, 976, 10.1086/428579 · doi:10.1086/428579
- van Hal, 2007, J Clin Microbiol, 45, 2486, 10.1128/JCM.00139-07 · DOI
- Cunningham, 2007, J Hosp Infect, 65, 24, 10.1016/j.jhin.2006.09.019 · doi:10.1016/j.jhin.2006.09.019
- Jones, 2007, Top HIV Med, 15, 48
- Mueller, 2007, Eur J Med Res, 12, 441
- Phillips, 2001, JAMA, 286, 2270, 10.1001/jama.286.18.2270 · DOI · Paper page
- Moore, 2007, Arch Intern Med, 167, 1752, 10.1001/archinte.167.16.1752 · DOI · Paper page
- Evans, 2004, Nature, 429, 464, 10.1038/nature02626 · DOI · Paper page
- Yin, 2007, Thromb Res, 120, 1, 10.1016/j.thromres.2006.10.021 · DOI · Paper page
- Flockhart, 2008, Genet Med, 10, 139, 10.1097/GIM.0b013e318163c35f · DOI · Paper page
- Anderson, 2007, Circulation, 116, 2563, 10.1161/CIRCULATIONAHA.107.737312 · DOI · Paper page
- Caraco, 2008, Clin Pharmacol Ther, 83, 460, 10.1038/sj.clpt.6100316 · DOI · Paper page
- Ando, 2007, Curr Opin Mol Ther, 9, 258
- Maitland, 2006, Trends Pharmacol Sci, 27, 432, 10.1016/j.tips.2006.06.007 · DOI
- Dumaual, 2007, Pharmacogenomics, 8, 293, 10.2217/14622416.8.3.293 · DOI
- Mallal, 2008, N Engl J Med, 358, 568, 10.1056/NEJMoa0706135 · DOI · Paper page
- Phillips, 2007, Curr Opin Allergy Clin Immunol, 7, 324, 10.1097/ACI.0b013e32825ea68a · DOI
- Yu, 2007, Expert Rev Mol Diagn, 7, 659, 10.1586/14737159.7.5.659 · DOI
- Facey, 2007, Health Technol Assess, 11, iii, 10.3310/hta11440 · DOI · Paper page
- Goldstein, 2005, Oncology, 69, 326, 10.1159/000089765 · doi:10.1159/000089765
- Avril, 2007, Future Oncol, 3, 215, 10.2217/14796694.3.2.215 · DOI
- Loprevite, 2007, Clin Cancer Res, 13, 6518, 10.1158/1078-0432.CCR-07-0805 · DOI
Cited by
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Recombinant pharmaceuticals from microbial cells: a 2015 update
Sanchez-Garcia, L., Martín, L., Mangues, R., Ferrer-Miralles, N., Vázquez, E., & Villaverde, A. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0437-3 · Cited by 339
Diverse functional roles of lipocalin-2 in the central nervous system
Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., & Suk, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.006 · Cited by 195
Metadata
- Authors
- Pene, F., Courtine, E., Cariou, A., & Mira, J.-P.
- Venue
- Critical Care Medicine
- Published
- 2009-01
- Volume
- 37
- Issue
- Supplement
- Pages
- S50-S58
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W4256007139
- Cited by
- 193
- References
- 1
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward theragnostics. https://app.cochat.ai/papers/10.1097/ccm.0b013e3181921349
- The paper
- Pene, F., Courtine, E., Cariou, A., & Mira, J.-P. (2009). Toward theragnostics. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181921349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.